ModernMedicine Resource Center More Topics

Ocular Allergy Resource Center

New ocular allergy drug’s MOA targets inflammation
New ocular allergy drug’s MOA targets inflammationA new, first-in-class, aldehyde-trap topical drop demonstrated rapid onset of action and sustained efficacy with an acceptable safety profile in a phase II clinical trial of patients with moderate-to-severe allergic conjunctivitis.
What clinicians should know about ocular allergies
What clinicians should know about ocular allergiesThe arrival of spring also signals the onset of ocular allergy season. Clinicians can prepare by knowing and recognizing the symptoms in their patients, as well as being informed about the latest therapies for this diagnosis.
Getting to the root cause of ocular allergyBeing armed with as much information as possible about a patient’s ocular allergies can make a major difference in treatment decisions, whether for dry eye or scheduling of ocular surgery.
What punctal plug delivery of dexamethasone means for allergic conjunctivitisTreatment of chronic allergic conjunctivitis with a sustained-release dexamethasone resulted in better clinical results because of the sustained and controlled delivery.
Allergy or dry eye: Which is it?Ocular surface disease may be multifactorial, presenting a challenge to the physician in making a correct diagnosis and management plan.
Rethinking once-daily dosing on allergy medicationsIdeally, an ocular allergy medication should provide clinically significant improvements of the annoying or even incapacitating ocular itch with minimal dosing. While this is a desirable goal, it leads to challenges of the amount of dosing to achieve this objective and patient compliance with such dosing.
How to improve diagnosis and treatment of allergy
How to improve diagnosis and treatment of allergyIf you think more allergy patients are landing in your chair every year, you’re absolutely correct. The prevalence of allergy is rising worldwide to near epidemic proportions and carries a significant burden for both the individual patient as well as healthcare systems globally.
What Thomas Edison and goldenrod teach us about allergyRight about now, you are probably wondering, “Is there a real connection between the plant and the late inventor?”
Allergy-free prescriptions: A need for information gives birth to a new platform
Allergy-free prescriptions: A need for information gives birth to a new platformThe next time your patient asks about inactive ingredients, you can find an answer quickly at www.allergyfreerx.com.
A new player in point-of-care allergy testing
A new player in point-of-care allergy testingWhat would be the response if I told you that prescribing an allergy medication outright was a bandage or knee-jerk approach? Now, before everyone comes after me with pitchforks, hear me out.